Mechanisms of Myocardial Infarction in Women With Non Obstructive Coronary Artery Disease
- Conditions
- Myocardial Infarction
- Interventions
- Procedure: cardiac imajing
- Registration Number
- NCT01953029
- Lead Sponsor
- Rambam Health Care Campus
- Brief Summary
The objective of our work to determine the mechanisms of myocardial infarction in women without obstructive coronary artery disease.
- Detailed Description
Cardiovascular disease is the leading cause of death for women. Acute coronary syndrome (ACS) is usually characterized by a sudden erosion of the endothelial wall or rupture of a plaque.However, women with ACS are less likely than men to have either classic symptoms or obstructive coronary artery disease but paradoxically have a worse prognosis. Different data from the literature indicate that there may be different pathophysiological mechanisms, afflicting men and women somewhat differently.Between 5% and 30% of patients with ACS undergoing coronary angiography are found to have non visible or non obstructive coronary disease (NOCD). This is 2-3 times more common in women than in men. Several pathogenetic mechanism of myocardial infarction (MI) in the absence of obstructive coronary artery disease (OCD) have been postulated, including among others atherosclerosis with plaque disruption that does not lead to luminal occlusion ,endothelial dysfunction, vasospasm , distal microembolization and microvascular dysfunction. However the data are extremely limited.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 80
- Women ≥ 18 years old, not pregnant
- with acute non ST elevation myocardial infarction (admitted within 12 hours from beginning of symptoms)
- who are candidates for coronary arteriography during the hospitalization. -
*Women with troponin elevation caused by other causes -
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description non obstructive coronary disease cardiac imajing non obstructive coronary disease
- Primary Outcome Measures
Name Time Method MORTALITY 1 YEAR
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Rambam Heath Care Campus
🇮🇱Haifa, Israel